Exagen's major customers
Exagen appears in 5 disclosed customer relationships between 2018 and 2025.
Get an email when Exagen's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Major customers of Exagen
Customers that Exagen named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.
Formerly disclosed
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Medicare | 25% | last FY 2024 | 7 years | FY 2024 · filed 11 Mar 2025 |
| Medicare Advantage | 20% | last FY 2024 | 7 years | FY 2024 · filed 11 Mar 2025 |
| Blue Shield | 12% | last FY 2021 | 4 years | FY 2021 · filed 20 Mar 2023 |
| Janssen SIMPONI | 12% | last FY 2020 | 1 year | FY 2020 · filed 22 Mar 2022 |
| UnitedHealthcare | 10% | last FY 2024 | 3 years | FY 2024 · filed 11 Mar 2025 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API